AR023562A1 - Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento - Google Patents

Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento

Info

Publication number
AR023562A1
AR023562A1 ARP000101863A ARP000101863A AR023562A1 AR 023562 A1 AR023562 A1 AR 023562A1 AR P000101863 A ARP000101863 A AR P000101863A AR P000101863 A ARP000101863 A AR P000101863A AR 023562 A1 AR023562 A1 AR 023562A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
tiazolidin
diona
understands
derived
Prior art date
Application number
ARP000101863A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR023562A1 publication Critical patent/AR023562A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Dihidrato de hidrocloruro de 5-[4-[2-N-metil-N-(2-piridil)amino)-etoxi]bencil]tiazolidina-2,4-diona caracterizado porque (i) proporciona un espectroinfrarrojo que contiene picos a 3.392, 2.739, 1.751, 1.325 y 713cm-1 y/o (ii) proporciona un modelo dedifraccion de rayos X a través de polvo (XRPD) quecontiene picos a 9,1, 12,0,15,7,16,3 y 19,8*2theta, un procedimiento para preparar dicho compuesto, una composicion farmacéutica que contiene dicho compuesto yel uso de dicho compuesto en medicina.
ARP000101863A 1999-04-20 2000-04-19 Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento AR023562A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9909041.7A GB9909041D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
AR023562A1 true AR023562A1 (es) 2002-09-04

Family

ID=10851901

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP000101868A AR023566A1 (es) 1999-04-20 2000-04-19 Un procedimiento para el dihidrato del hidrocloruro derivado de la tiazolidina-2,4-diona
ARP000101863A AR023562A1 (es) 1999-04-20 2000-04-19 Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP000101868A AR023566A1 (es) 1999-04-20 2000-04-19 Un procedimiento para el dihidrato del hidrocloruro derivado de la tiazolidina-2,4-diona

Country Status (42)

Country Link
EP (2) EP1173436B1 (es)
JP (2) JP4283449B2 (es)
KR (1) KR100601244B1 (es)
CN (2) CN1327447A (es)
AP (1) AP1562A (es)
AR (2) AR023566A1 (es)
AT (1) ATE268770T1 (es)
AU (2) AU4130900A (es)
BG (1) BG65864B1 (es)
BR (1) BR0009897A (es)
CA (1) CA2382036A1 (es)
CO (1) CO5170422A1 (es)
CZ (1) CZ300653B6 (es)
DE (1) DE60011419T2 (es)
DK (1) DK1173436T3 (es)
DZ (1) DZ3162A1 (es)
EA (1) EA004232B1 (es)
EG (1) EG24063A (es)
ES (1) ES2218146T3 (es)
GB (1) GB9909041D0 (es)
HK (1) HK1045151B (es)
HR (1) HRP20010770B1 (es)
HU (1) HUP0200865A3 (es)
IL (1) IL146078A0 (es)
MA (1) MA26783A1 (es)
MX (1) MXPA01010696A (es)
MY (1) MY126034A (es)
NO (1) NO320609B1 (es)
NZ (1) NZ515166A (es)
OA (1) OA11866A (es)
PE (1) PE20010050A1 (es)
PL (1) PL351135A1 (es)
PT (1) PT1173436E (es)
RS (1) RS50136B (es)
SI (1) SI1173436T1 (es)
SK (1) SK284991B6 (es)
TR (1) TR200103040T2 (es)
TW (1) TWI277616B (es)
UA (1) UA71615C2 (es)
UY (1) UY26112A1 (es)
WO (1) WO2000063205A2 (es)
ZA (1) ZA200108720B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
AU2002343050A1 (en) * 2001-11-21 2003-06-10 Smithkline Beecham P.L.C. 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
CZ296468B6 (cs) * 2004-06-10 2006-03-15 Zentiva, A. S. Sul kyseliny fosforecné s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionema zpusob její prípravy
CZ2004844A3 (cs) * 2004-07-27 2006-03-15 Zentiva, A. S Sul kyseliny stavelové s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionu azpusob její prípravy a její pouzití
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
OA11866A (en) 2006-03-02
SK14902001A3 (sk) 2002-02-05
HRP20010770A2 (en) 2002-10-31
EA004232B1 (ru) 2004-02-26
CO5170422A1 (es) 2002-06-27
SI1173436T1 (en) 2004-12-31
BR0009897A (pt) 2002-04-16
TWI277616B (en) 2007-04-01
ATE268770T1 (de) 2004-06-15
UY26112A1 (es) 2000-12-29
PE20010050A1 (es) 2001-03-10
NO320609B1 (no) 2005-12-27
NO20015104D0 (no) 2001-10-19
WO2000063205A3 (en) 2001-01-25
RS50136B (sr) 2009-03-25
CN1327447A (zh) 2001-12-19
BG106112A (bg) 2002-05-31
BG65864B1 (bg) 2010-03-31
KR20010110791A (ko) 2001-12-13
EP1411055A1 (en) 2004-04-21
MA26783A1 (fr) 2004-12-20
CN101134756A (zh) 2008-03-05
DE60011419D1 (de) 2004-07-15
NZ515166A (en) 2004-02-27
EP1173436A2 (en) 2002-01-23
HK1045151B (zh) 2005-03-18
UA71615C2 (uk) 2004-12-15
IL146078A0 (en) 2002-07-25
JP2002542242A (ja) 2002-12-10
PL351135A1 (en) 2003-03-24
JP4283449B2 (ja) 2009-06-24
HUP0200865A2 (en) 2002-08-28
WO2000063205A2 (en) 2000-10-26
PT1173436E (pt) 2004-10-29
GB9909041D0 (en) 1999-06-16
SK284991B6 (sk) 2006-04-06
AU2755202A (en) 2002-05-16
HK1045151A1 (en) 2002-11-15
CA2382036A1 (en) 2000-10-26
KR100601244B1 (ko) 2006-07-19
AU4130900A (en) 2000-11-02
HRP20010770B1 (en) 2005-06-30
YU81501A (sh) 2004-07-15
TR200103040T2 (tr) 2002-04-22
DE60011419T2 (de) 2005-06-16
ZA200108720B (en) 2002-11-28
AP2001002331A0 (en) 2000-04-19
ES2218146T3 (es) 2004-11-16
EA200101101A1 (ru) 2002-04-25
DZ3162A1 (fr) 2000-10-26
JP2009143954A (ja) 2009-07-02
MY126034A (en) 2006-09-29
NO20015104L (no) 2001-12-19
AU765911B2 (en) 2003-10-02
MXPA01010696A (es) 2002-06-04
HUP0200865A3 (en) 2005-04-28
CZ300653B6 (cs) 2009-07-08
EG24063A (en) 2008-05-08
EP1173436B1 (en) 2004-06-09
AR023566A1 (es) 2002-09-04
CZ20013759A3 (cs) 2002-05-15
AP1562A (en) 2006-02-01
DK1173436T3 (da) 2004-09-27

Similar Documents

Publication Publication Date Title
AR066982A2 (es) Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos
AR011759A1 (es) Compuesto derivado de fenoximetilpiperidina, procedimientos para su preparacion, una composicion farmaceutica, el uso del mismo para la preparacion de un medicamento, para la preparacion de un producto intermedio, un solvato y un envase
RU93043528A (ru) Моногидрат 5-(2-(4-(1,2-бензотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2н-индол-2-он хлоргидрата, способ его получения, фармацевтическая композиция, способ лечения
ATE144503T1 (de) Thiazolidin-2,4-dionderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
AR023562A1 (es) Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento
UY26120A1 (es) Nuevo compuesto farmacéutico art 127 de la ley 17164
UY26121A1 (es) Nuevo compuesto farmacéutico
AR017430A1 (es) Un hidrato de la sal del acido maleico de la 5[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona, un proceso para su preparacion,composicion farmaceutica que lo contiene y uso del mismo para la fabricacion de un medicamento
DE59909606D1 (de) Substituierte 1,3-diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)-propanolderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
AR023563A1 (es) Monohidrato de hidrocloruro de un derivado de tiazolidin-2,4-diona, una composicion farmaceutica y el uso del mismo para la fabricacion de un medicamento
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
ES2076894A1 (es) Derivados de 2-(4-(4-azolibutil)-1-piperacinil)-5-hidroxipirimidina, su preparacion y su aplicacion como medicamentos.
CY1105903T1 (el) Ενα παραγωγο της θειαζολιδενεδιονης και η χρηση του σαν αντιδιαβητικο
CY1107252T1 (el) Τρυγικο αλας παραγωγου της θειζολιδινοδιονης
ECSP003434A (es) Nuevos compuestos
ECSP003435A (es) Nuevos compuestos
NZ243552A (en) 2-[2-(4-methoxy-2-pyridinyl)phenylsulphinyl]-1h-benzimidazole derivatives, preparation and pharmaceutical compositions thereof
ECSP034466A (es) Farmaceutico novedoso
ATE232859T1 (de) Benzofuranderivate, verfahren zu ihrer herstellung, ihre anwendung als medikament und sie enthaltende pharmazeutische zubereitungen
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
DE69117853D1 (de) Topisch anzuwendendes pulverförmiges Arzneimittel, das zyklische AMP-Derivate enthält
ATE334675T1 (de) Arzneimittel enthaltend substituierte 2,5- diaminomethyl-1h-pyrrole

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FG Grant, registration